In addition, synthetic AVP (desmopressin) is used as procoagulant treatment, for example, in von Willebrand’s disease (vWD), as it increases platelet release of coagulation factor VIII and von Willebrand factor after administration. Here, F8 is linked to platelet-type von Willebrand disease.